about
Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem"Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine DrugInhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte CulturesCell cycle analysis of primary sponge cell culturesPhakellistatins: An Underwater Unsolved Puzzle.How Environmental Factors Affect the Production of Guanidine Alkaloids by the Mediterranean Sponge Crambe crambe.Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactivesBrominated compounds from marine sponges of the genus Aplysina and a compilation of their 13C NMR spectral data.Red Sea Suberea mollis Sponge Extract Protects against CCl4-Induced Acute Liver Injury in Rats via an Antioxidant MechanismAntiviral lead compounds from marine sponges.Antimicrobial activity of heterotrophic bacterial communities from the marine sponge Erylus discophorus (Astrophorida, Geodiidae)Anti-biofilm compounds derived from marine sponges.Antinociceptive and anti-inflammatory activities of crude methanolic extract of red alga Bryothamnion triquetrum.Sources of secondary metabolite variation in Dysidea avara (Porifera: Demospongiae): the importance of having good neighbors.Mariculture and natural production of the antitumoural (+)-discodermolide by the Caribbean marine sponge Discodermia dissoluta.Antinociceptive activity of Stephanolepis hispidus skin aqueous extract depends partly on opioid system activation.Application of diffusion growth chambers for the cultivation of marine sponge-associated bacteria.Seasonal variation of Fatty acids and stable carbon isotopes in sponges as indicators for nutrition: biomarkers in sponges identified.Long-term experimental in situ farming of Crambe crambe (Demospongiae: Poecilosclerida).The Development of Sustainable Saltwater-Based Food Production Systems: A Review of Established and Novel Concepts
P2860
Q26746924-D66268AB-89F2-44F9-82A3-C195D7589F22Q26772014-CE3AA484-4493-4543-B7C4-808EFB39B40AQ28547985-E556AE89-51F8-43EE-9F10-266BA9B19D4CQ28740760-FEA59622-22C3-4ECE-BC3A-8172B62B8BA4Q33365075-246F25C5-FF4E-43E7-BA07-0F232F58A13EQ33833417-3939D960-8DE6-4673-8FC9-9FE807090D5BQ34091904-D4758C01-AE6B-4D65-BFC7-FA0EF1E71A7BQ34098038-28AA055F-AF2A-4E90-9913-D042609991B2Q34146034-CBADDE57-DCA4-4EB3-9889-E7E0C46314C3Q34152399-129B1447-C0EF-4FC0-8CE0-8A4E0034BDF3Q35043670-2D07B943-9F6C-4709-8FB8-BF4344E51D69Q35534934-E7026490-C300-462F-A19B-87C227FE33D7Q36329853-C5ED530D-957F-419E-9133-05D9B4C1A38EQ40255204-24ED251B-4E27-4F9B-852E-BA7F7C07E6CEQ42439397-32221465-EABC-4F88-B099-ACB240C7330BQ43101286-5EFF81D4-EE34-46AA-A3D5-274788215675Q44908817-53D10942-A849-40B0-B7DE-97876D14324EQ53477542-532C8914-1361-4993-B613-929979D20407Q55334260-D513A905-D81D-4D0D-A418-31786197F0BAQ57529496-23630E5A-0223-4A9A-90BB-B5158061868A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Towards commercial production of sponge medicines.
@ast
Towards commercial production of sponge medicines.
@en
type
label
Towards commercial production of sponge medicines.
@ast
Towards commercial production of sponge medicines.
@en
prefLabel
Towards commercial production of sponge medicines.
@ast
Towards commercial production of sponge medicines.
@en
P2093
P2860
P921
P356
P1433
P1476
Towards commercial production of sponge medicines.
@en
P2093
Dirk Martens
Marieke Koopmans
Rene H Wijffels
P2860
P304
P356
10.3390/MD7040787
P577
2009-12-02T00:00:00Z